I would not want to be short this stock. EPS of $0.36 last quarter with margin expansion. DHRM keeps putting out good news and their products are gaining serious traction. See below:
In April 2012, Dehaier renewed its strategic cooperation agreement with Timesco of London Ltd ("Timesco"). The agreement appointed Dehaier as the exclusive distributor for Timesco's CXL and Eclipse series laryngoscope products in mainland China for three years.
In May 2012, the Company extended its exclusive distribution authorization with INTERMEDICAL ("IMD"), to distribute IMD's RADIUS C-arm X-ray machines in mainland China. The extended term runs through 2014.
In June 2012, Dehaier entered a three-year strategic mutual cooperation agreement with HEYER Medical AG ("Heyer"). According to this agreement, Dehaier will continue to be one of the key Chinese distributors for Heyer's anesthesia machines and the exclusive distributor of its nebulizers in China.
Also in June 2012, the Company co-developed a "High-Efficiency Oxygen Inhaler" with Dr. Ding Jianzhang of Beijing Haidian Hospital. This inhaler is expected to begin selling in mainland China in the third quarter of 2012. The portable device is designed for use in homecare oxygen therapy, emergency treatment, disaster relief activities and high-altitude settings.
Between April and June 2012, the company obtained software copyrights from China's National Copyright Administration for four of its proprietary technologies, including (1) Analysis and Monitoring Software of Adsorption Tower Oxygen Generation Process, (2) Dehaier Homecare CPAP Controlling Software, (3) Ventilator of CPAP Controlling Software and (4) Air Compressor Controlling Software. These copyrights have been approved for 50 years from the grant date.
In July 2012, Dehaier received approval from China's State Food and Drug Administration ("SFDA") for its proprietary homecare medical CPAP device, the DHR-CPAP-C5.
